Last reviewed · How we verify
NCT04875247
IOLMASTER 700 Central Topography Workflow Study.
trial testing IOLMaster 700 with central topography in Cataract in 100 participants. Completed in 9 September 2021.
9 September 2021
Quick facts
| Lead sponsor | OFTALVIST (Oftalmología Vistahermosa S.L) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 12 May 2021 |
| Primary completion | 9 September 2021 |
| Estimated completion | 9 September 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- IOLMaster 700 with central topography
- IOLMaster 700 without central topography plus Cassini
- IOLMaster 700 without central topography plus Pentacam
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
OFTALVIST (Oftalmología Vistahermosa S.L)
Who can join
50 and older, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The use of ocular biometers like IOLMaster 700, is a common practice to identify several ocular parameters such as the keratometry of the cornea and the axial length of the eye, which are necessary for calculating the power of the intraocular lens in cataract surgery. However, the additional use of other devices, such as Cassini and Pentacam is used to obtain more information of the central topography of the eye. Recently, a new version of the IOLMaster 700 equipment that provides much more detailed information than in its previous version has been presented. The objective of this study is to measure the time that the new IOLMaster 700 takes to perform these measurements of the central topography and compare it with the time it takes using the central topography using the standard IOLMaster 700 version with Cassini on one hand and Pentacam on the other. It is hypothesized that the use of the new version of the IOLMaster 700 equipment alone can reduce the time of measurements and improve the clinic workflow.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acquisition Time for Swept-Source Optical Biometry Plus Corneal Power Measurement During Cataract Evaluation.
Ruiz-Mesa R, Ruiz-Santos M, Blanch-Ruiz J, Jiménez-Nieto A. · · 2022 · cited 5× · PMID 35282169 · DOI 10.2147/opth.s351845
Verify or expand the search:
- PubMed search for NCT04875247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other OFTALVIST (Oftalmología Vistahermosa S.L) trials
Trials by the same sponsor.
- NCT05239715 — Evaluation of Three SS-OCT and One PCI Optical Biometers in Eyes With Dense Cataract · completed
- NCT05058274 — Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI) · completed
- NCT05053620 — Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Us · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04875247 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OFTALVIST (Oftalmología Vistahermosa S.L)
- Last refreshed: 17 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04875247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing